Skip to main content

Table 1 Clinical and virological follow-up at t1 (n = 48 patients) and t2 (n = 47 patients)

From: Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique

 

t1

t2

CD4 count (cells/μl)a

234 (113–322)

236 (136–386)

HIV RNA (log10 copies/ml)a

3.8 (3.5–4)

3.9 (3,5–4.5)

Hb (g/dL)a

12.6 (11.3–13.1)

12.1 (11.2–13.3)

BMI (Kg/m2)a

22.2 (20.7–25.3)

21.9 (20.5–24.7)

Adherence (%)a

100 (92–100)

100 (92–100)

Percent of patients with <95% adherence to pharmacy appointments

41.7

41.3

  1. BMI Body mass index
  2. amedian (IQR)